The newly approved technology delivers low-dose microcurrents through closed eyelids to stimulate retinal cells. Canadian medical device company MacuMira Medical Devices recently introduced the first ...
Clareon Panoptix Pro IOL achieves 94% light utilization, enhancing light distribution and optical image contrast for improved patient outcomes. The IOL offers +2.17 diopter intermediate and +3.25 ...
Alcon Inc. (NYSE:ALC) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 20, Alcon Inc. (NYSE:ALC) announced the approval of the Clareon PanOptix Pro intraocular lens for patients in ...
The Clareon PanOptix Pro Trifocal IOL is a type of multifocal IOL used to focus images clearly onto the back of your eye (retina) to allow clear vision after the cataract removal. In addition, the ...
Alcon Inc. ALC recently introduced the Clareon PanOptix Pro intraocular lens (IOL) for cataract patients in the United States. PanOptix Pro leverages proprietary ENLIGHTEN NXT Optical technology to ...
GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...
The following is a summary of “Visual Outcomes and Quality of Vision After Bilateral Implantation of a Hydrophobic Acrylic Trifocal Intraocular Lens,” published in the January 2025 issue of ...
Please provide your email address to receive an email when new articles are posted on . Johnson & Johnson has expanded the roll-out of its presbyopia-correcting, full-visual range Tecnis Odyssey IOL, ...
A new modified intraocular lens (IOL) power selection method was developed, which has more accurate power calculation than the existing method. Dr. Youngsub Eom of Department of Ophthalmology of Korea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results